RPG Life Sciences Ltd Financials

RPG Life Sciences Ltd Financial Statement

RPG Life Sciences Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2024	Jun 2024	Mar 2024
Revenue	174.15	167.79	128.64
Operating Expense	153.58	126.35	106.27
Net Profit	4.20	26.76	13.24
Net Profit Margin	2.41	15.95	10.29
Earning Per Share	2.54	16.18	8.01
EBIDTA	20.46	41.71	23.32
Effective Tax Rate	52.41	22.95	24.36

Particulars	Sep 2024
Revenue	174.15
Operating Expense	153.58
Net Profit	4.20
Net Profit Margin	2.41
Earning Per Share	2.54
EBIDTA	20.46
Effective Tax Rate	52.41

RPG Life Sciences Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	582.05	512.81	440.16
Operating Expenses Annual	453.90	410.12	353.80
Operating Profit Annual	135.36	107.49	89.35
Interest Annual	0.45	0.31	0.52
Depreciation	10.41	8.71	8.83
Net Profit Annual	87.66	67.64	51.48
Tax Annual	30.18	24.04	21.69

Particulars	Mar 2024
Total Revenue Annual	582.05
Operating Expenses Annual	453.90
Operating Profit Annual	135.36
Interest Annual	0.45
Depreciation	10.41
Net Profit Annual	87.66
Tax Annual	30.18

RPG Life Sciences Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	24.82	56.94	40.36
Cash Flow from Operations	94.36	90.82	64.75
Cash Flow from Investing	-79.15	-105.81	-34.66
Cash Flow from Financing	-20.31	-17.12	-13.51
Cash Flow at the End	19.72	24.83	56.94

Particulars	Mar 2024
Cash Flow at the Beginning	24.82
Cash Flow from Operations	94.36
Cash Flow from Investing	-79.15
Cash Flow from Financing	-20.31
Cash Flow at the End	19.72

RPG Life Sciences Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	23.43	21.12	20.50
PBIT Margin (%)	20.49	18.10	16.94
PBT Margin (%)	6.26	2.36	4.92
Net PROFIT Margin (%)	15.06	13.19	11.70
Return On Networth / Equity (%)	25.69	24.01	21.80
Return On Networth /Employed (%)	34.25	32.15	30.57
Return On Assets (%)	25.15	23.48	21.05
Total Debt / Equity (X)	TBA	TBA	0.01
Asset Turnover Ratio (%)	1.67	1.78	1.80

Particulars	Mar 2024
PBDIT Margin (%)	23.43
PBIT Margin (%)	20.49
PBT Margin (%)	6.26
Net PROFIT Margin (%)	15.06
Return On Networth / Equity (%)	25.69
Return On Networth /Employed (%)	34.25
Return On Assets (%)	25.15
Total Debt / Equity (X)	TBA
Asset Turnover Ratio (%)	1.67

RPG Life Sciences Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	125.06	134.67	109.32
Total Current Assets Annual	298.09	264.05	206.91
Non Current Assets Annual	214.78	155.30	137.70
Total Shareholders Funds Annual	374.85	307.60	255.77
Total Assets Annual	512.87	419.35	344.61

Particulars	Mar 2024
Fixed Assets Annual	125.06
Total Current Assets Annual	298.09
Non Current Assets Annual	214.78
Total Shareholders Funds Annual	374.85
Total Assets Annual	512.87

RPG Life Sciences Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Dec 24, 2024, RPG Life Sciences Ltd has a market capitalization of 2,530.80 Cr. Value Research classifies it as a Mid-Cap company.

Yes, RPG Life Sciences Ltd is debt-free with a debt-to-equity ratio of 0.00.

In FY 2023 , RPG Life Sciences Ltd recorded a total revenue of approximately 582.05 Cr marking a significant milestone in the company's financial performance.

RPG Life Sciences Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.5% and 0.1% annually, respectively..

RPG Life Sciences Ltd's current PE ratio is 28.87.

RPG Life Sciences Ltd's ROCE averaged 29.8% from the FY ending March 2022 to 2024, with a median of 29.6%. It peaked at 31.3% in March 2024, reflecting strong capital efficiency over the period..

RPG Life Sciences Ltd's latest EBIT is Rs. 118.29 Cr, surpassing the average EBIT of Rs. 94.66 Cr over the 5 years..